Overview
The virus transport medium consists of a sampling swab, a tube for containing the viral sample, and outer packaging. There are two main types of viral transport medium available: inactivated and non-inactivated. The single-use viral transport medium with a tube is the company's star product. It is ideal for the nucleic acid extraction and transport of samples. It can also be used for human nasopharyngeal virus samples. To make the most of the single-use swabs, consider using nylon fibers instead of cotton. Cotton swabs are unable to collect viruses and bacteria, while nylon swabs can handle these types of samples. Furthermore, flocked swabs can elute samples faster and contain more than 95% of the samples.
To Get Complete Industry Insights, Grab Sample PDF Copy Here: https://bit.ly/3Kk2J2U
Drivers
Rising incidences of COVID-19 infections across the globe, in parallel to the growing number of virus-related fatalities, are expected to propel the growth of the global swab viral transport medium market over the forecast period.
Furthermore, the growing prominence of rapid testing kits for the detection of viral infection, combined with the accelerated approval pathway for novel testing kits, is expected to boost the growth of the global swab viral transport medium market during the forecast period. For instance, in March 2022, Thermo Fisher Scientific developed a new non-hazardous viral inactivation medium, InhibiSURE, to support the safe transport and collection of the SARS-CoV-2 virus.
Restraints
The high cost of equipment and the scarcity of specialized professionals are expected to limit the growth of the global swab viral transport medium market.
Opportunities
Rising demand for at-home rapid antigen test kits amidst increasing spending on medical services is expected to provide lucrative growth opportunities for players in the global swab viral transport medium market.
Regional Analysis
Asia Pacific is expected to experience robust growth over the forecast period in the global swab viral transport medium market. Increasing cases of community transmission at public places, a large patient pool, and an accelerated approval pathway for novel products are driving the growth of the swab viral transport medium market in this region.
North America is expected to witness significant growth during the forecast period in the global swab viral transport medium market. Rising expenditure on the healthcare sector and an increasing volume of COVID-19 patients are propelling the growth of the swab viral transport medium market in this region.
Competitive Landscape
Major companies contributing to the global swab viral transport medium market include VIRCELL, MWE, Hardy Diagnostics, Laboratory Corporation of America, Puritan Medical Products, Thermo Fisher Scientific, Trinity Biotech, Copan, DiaSorin Molecular, Starplex Scientific, MANTACC, and HiMedia Laboratories.
Key Developments
• In May 2022, Rhinostics announced that Health Canada had approved its RHINOstic Automated Nasal Swab for detection of COVID-19 infections.
• In April 2022, the South Korean Ministry of Food and Drug Safety (MFDS) approved PCL’s saliva-based COVID-19 test kits to conduct rapid antigen tests at airports to curb the transmission of the virus in the country.
No comments:
Post a Comment